mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / brixadi

Brixadi

Buprenorphine
  o--o
   \/
   /\
  o--o

Buprenorphine is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietyBuprenorphine
administration routeSubcutaneous
price comparison status2 snapshots
safety signal rating54 / 100
Partial Opioid Agonist [EPC]openFDA NDC seedopenFDA NDC64 mg/.18mL
price index

Typical Class Estimates

⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Partial Opioid Agonist [EPC].
$24.50USvsCA$14.20CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 7526 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Rising Fast3M: +2.6%12M: +0.4%
Jul 2025
▄▇███▆▃ ▂▅
Jun 2026
Jan 2026$23.84
Feb 2026$23.60
Mar 2026$23.50
Apr 2026$23.45
May 2026$23.73
Jun 2026$24.11
01 / chemistryBraeburn Inc.

Ingredient Breakdown

active moietyBuprenorphine
formulationSubcutaneous Partial Opioid Agonist [EPC]
mechanism of action

Partial Opioid Agonist [EPC]

available strengths
64 mg/.18mL

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
  2. Read the official label for route-specific directions, contraindications, and storage.
  3. Ask a clinician or pharmacist before substituting products across countries or formulations.
  4. Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.

Side-Effect Signals

  • label-specific reactions
  • allergic reaction
  • interaction risk
  • dose/formulation confusion
  • urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches
BuprenorphineBuprenorphineBuprenorphineBuprenorphineBuprenorphineBuprenorphineBuprenorphineBuprenorphine